tbResList Print — CPT Camptothecin

Filters: qv=204, qv2=%, rfv=%

Product

CPT Camptothecin
Description: <b>Camptothecin (CPT)</b> and its derivatives function as inhibitors of topoisomerase and as potent anticancer agents against a variety of cancers. <br>
Camptothecin is a cytotoxic quinoline alkaloid that is isolated from the bark and fruit of the Camptotheca acuminata tree, native to China. It is a topoisomerase I inhibitor, which means it blocks the enzyme topoisomerase I, an essential enzyme in DNA replication.<br>
Camptothecin derivatives, such as irinotecan and topotecan, have been approved for the treatment of various types of cancer, including colorectal, ovarian, and small cell lung cancer. These derivatives have improved solubility and stability compared to camptothecin, making them more suitable for clinical use.<br>

Pathway results for Effect on Cancer / Diseased Cells

Redox & Oxidative Stress

GPx↓, 1,   GSH↓, 1,   ROS↑, 1,   SOD↓, 1,  

Mitochondria & Bioenergetics

MMP↓, 1,   Raf↓, 1,  

Cell Death

Akt↓, 1,   BAX↑, 1,   Bcl-2↓, 1,   Bcl-xL↓, 1,   BID↑, 1,   Casp3↑, 1,   Casp6↑, 1,   Casp9↑, 1,   Cyt‑c↑, 1,   JNK↑, 1,   p38↑, 1,  

DNA Damage & Repair

P53↑, 1,  

Cell Cycle & Senescence

P21↑, 1,  

Proliferation, Differentiation & Cell State

ERK↓, 1,   MAP2K1/MEK1↓, 1,  
Total Targets: 21

Pathway results for Effect on Normal Cells

Total Targets: 0

Research papers

Year Title Authors PMID Link Flag
2018Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer CellsYu-Guo YuanPMC6311846https://pmc.ncbi.nlm.nih.gov/articles/PMC6311846/0